Fenwick represented Prometheus Alternative Investments on the deal. Fintech startup Prometheus Alternative Investments, Inc., announced its $5 million seed round. The investment was led by 8VC/Joe Lonsdale...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised TrialSpark on the deal. TrialSpark, a technology-driven pharma company that runs end-to-end clinical trials, announced its $156 million Series C financing. The round...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Velo3D on the deal. Velo3D Inc., a leading additive manufacturing technology company for high-value metal parts, announced its public listing on the New...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Imgur on the deal. Imgur, Inc., a popular image-sharing and hosting platform, announced its acquisition by MediaLab, a holding company investing in media...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised tinyBuild on the deal. Video game label tinyBuild (AIM: TBLD) announced its acquisition of Bad Pixel, the development studio behind the popular open-world...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Remitly on the deal. Davis Polk advised several underwriters on the deal. Remitly Global, Inc. (Nasdaq: RELY), a mobile-first provider of remittances...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented EngageSmart, while Fenwick & West advised the underwriters on the deal. EngageSmart (NYSE: ESMT) announced its initial public offering. The company is a leading...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Ripple Foods on the deal. Ripple Foods, a leader in the plant-based dairy alternative space, announced its $60 million Series E financing....
You must be a Standard 1 Year member to access this content.
Fenwick & West advised DICE Therapeutics on the deal. DICE Therapeutics (Nasdaq: DICE), a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Coinbase on the deal. Coinbase Global, Inc. (Nasdaq: COIN), a leading provider of end-to-end financial infrastructure and technology for the cryptoeconomy, announced its...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Opensignal on the deal. Opensignal, a mobile analytics company specializing in quantifying mobile network experience, announced its acquisition by Comlinkdata, a leader in...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Vanqua Bio on the deal. Vanqua Bio, a biopharmaceutical company dedicated to discovering and developing next-generation medicines for neurodegenerative diseases, announced its $85...
You must be a Standard 1 Year member to access this content.
